Stefania Zamboni

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Prognostic impact of tumor size in low-risk upper tract urothelial carcinoma: A multi-institutional analysis.

Prognostic impact of tumor size in low-risk upper tract urothelial carcinoma: A multi-institutional analysis.

Journal: The French journal of urology

Published: April 30, 2026

Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.

Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.

Journal: World journal of urology

Published: February 10, 2026

Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study).

Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study).

Journal: Bone

Published: January 12, 2026

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 08, 2025

Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.

Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes.

Journal: European urology oncology

Published: October 15, 2025

Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer.

Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer.

Journal: World journal of urology

Published: October 07, 2025

Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Temporal trends and clinical determinants of urinary diversion after radical cystectomy.

Journal: BJU international

Published: October 06, 2025

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

Journal: World journal of urology

Published: July 05, 2025

Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study.

Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study.

Journal: BJU international

Published: May 22, 2025

Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study.

Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational Study.

Journal: European urology open science

Published: May 07, 2025

Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer myth.

Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer myth.

Journal: World journal of urology

Published: April 02, 2025

The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates.

The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidates.

Journal: BJU international

Published: March 26, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026